It is a pharma private limited company based in Muzaffarnagar, Uttar Pradesh, India, established in 2010.
2010 | Muzaffarnagar, Uttar Pradesh, India | ActiveYati Pharmaceuticals Private Limited, a active private limited company, was established on 31 August 2010 in Muzaffarnagar, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100UP2010PTC063660. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 35 professional, Its leadership includes Akhilesh Kumar Singh (Director), Bhupendra Singh (Director), Anil Bhatnagar (Whole-Time Director). Past directors included Ajay Kumar. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at 161- Iind Floor, Shiva Complex, Dwarika Puri, Muzaffarnagar, Uttar Pradesh, 251001.
U24100UP2010PTC063660
063660
31 August 2010
₹0.50 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Yati Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akhilesh Kumar Singh | Director | 26 Dec 2011 | Current |
| Bhupendra Singh | Director | 29 Oct 2011 | Current |
| Anil Bhatnagar | Whole-Time Director | 29 Oct 2011 | Current |
| Deependra Singh Malik | Director | 31 Aug 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Yati Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 62.52% increase. The company also saw a substantial improvement in profitability, with a 137.07% increase in profit. The company's net worth Soared by an impressive increase of 46.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Yati Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2020 | State Bank Of India | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Yati Pharmaceuticals has a workforce of 35 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Yati Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yati Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Yati Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was documented.
The activity Yati Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity A charge with State Bank Of India amounted to Rs. 2.00 M with Charge ID 100430728 was registered on 14 Feb 2020. was completed.
Progress on Akhilesh Kumar Singh was appointed as a Director was appointed as a Director on 26 Dec 2011 & has been associated with this company since 13 years 11 months . was documented.
Progress on Bhupendra Singh was appointed as a Director was appointed as a Director on 29 Oct 2011 & has been associated with this company since 14 years 1 month . was documented.
Anil Bhatnagar was appointed as a Whole-time director was appointed as a Whole-time director on 29 Oct 2011 & has been associated with this company since 14 years 1 month . was recorded as a recent event.
The CIN of Yati Pharmaceuticals Private Limited is U24100UP2010PTC063660.
Yati Pharmaceuticals Private Limited is headquartered at 161- Iind Floor, Shiva Complex, Dwarika Puri, Muzaffarnagar, Uttar Pradesh, 251001.
Yati Pharmaceuticals Private Limited was incorporated on 31 August 2010.
The current directors of Yati Pharmaceuticals Private Limited are
The primary industry of Yati Pharmaceuticals Private Limited is Trade.
Yati Pharmaceuticals Private Limited is unlisted.
The authorized capital of Yati Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Yati Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX